← Leaderboards
Angela Marie Pollard
University Of Wisconsin-Madison
$2,400,109
Attributed
$2,400,109
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $799.6K · FY2008–14$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,400,109 · 5
By mechanism
R44$1,030,274 · 1
R42$672,768 · 1
R41$300,000 · 1
R43$257,221 · 1
F32$139,846 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Marin Leigh Schweizer$4,424,967
- Vanessa Sperandio$30,589,180
- Daniel R Noguera$2,245,309
- Gregory W Harrington$241,097
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseInfectionIn VivoCellsMeasurementLibrariesAcuteLifeStagingNovel TherapeuticsGenesCytokineDrug Delivery SystemsCystCytokine ActivationImmune ResponseAntimicrobialCodeComplementExonsBioterrorismBirdsAcquired Immunodeficiency SyndromeFetal
Grant awards (8)
Anti-biofilm agents for the treatment of pulmonary infection in cystic fibrosis p$672,768
R42 · FY2014 · AI · contact PI
Targeting Oral Biofilms with 2-Aminoimidazole/Triazole Conjugates$499,586
R44 · FY2013 · DE · contact PI
Evaluation of a new class of molecules for treating MRSA infective endocarditis$300,000
R41 · FY2013 · AI · contact PI
Targeting Oral Biofilms with 2-Aminoimidazole/Triazole Conjugates$530,688
R44 · FY2012 · DE · contact PI
Small Molecules to Enhance Bacterial Susceptibility to Antiseptics$257,221
R43 · FY2012 · AI · contact PI
Employing Toxoplasma gondii virulence mutants to examine protective immunity$38,490
F32 · FY2010 · AI · contact PI
Employing Toxoplasma gondii virulence mutants to examine protective immunity$51,710
F32 · FY2009 · AI · contact PI
Employing Toxoplasma gondii virulence mutants to examine protective immunity$49,646
F32 · FY2008 · AI · contact PI